Income statement
USD
Annual
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 7M | 6M | 3M | 14M | 11M |
| Gross Profit | 7M | 6M | 3M | 14M | 11M |
| Operating Income | 3M | 2M | -940K | 7M | 4M |
| EBITDA | 84M | 54M | -82M | 15M | 59M |
| Net Income | 68M | 43M | -111M | 19M | 17M |
| EPS (Diluted) | — | — | — | — | — |
Financial Services
Live Price
Offline$18.80
+0.64% today
1Y Change
+16.70%
Window
Jun 27, 2025 → Jun 17, 2026
Coverage: 244 bars · Jun 27, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Buffalo Early Stage Growth Fund (BUFOX) is a Financial Services stock with a market cap of $60.00M. The stock last traded around $18.80 and up 16.7% across the available one-year price window (Jun 27, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +21.2%, EPS growth of +56.8%, a dividend yield of 4.8%. What stands out right now is revenue +21.2%, EPS +56.8%, free cash flow +159.4% with operating margin 39.3% and ROIC 0.5%. The dividend matters to the case here, with a current yield around 4.8%. Valuation already assumes a fairly strong business story at price/sales 8.8. Stock Foundry combines BUFOX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BUFOX
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BUFOX Max Drawdown
-16.51%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BUFOX and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$10.9M
-20.6% YoY
FY Net Income
$17.2M
-7.0% YoY
Free Cash Flow
$38.5M
-29.9% YoY
Revenue Growth
+21.2%
EPS Growth
+56.8%
Gross Margin
100.0%
Net Margin
967.9%
Income statement
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 7M | 6M | 3M | 14M | 11M |
| Gross Profit | 7M | 6M | 3M | 14M | 11M |
| Operating Income | 3M | 2M | -940K | 7M | 4M |
| EBITDA | 84M | 54M | -82M | 15M | 59M |
| Net Income | 68M | 43M | -111M | 19M | 17M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 13M | 6M | 7M | 10M | 6M |
| Total Assets | 427M | 366M | 313M | 587M | 629M |
| Total Liabilities | 117M | 101M | 63M | 189M | 204M |
| Shareholder Equity | 310M | 266M | 250M | 398M | 425M |
| Total Debt | 79M | 0 | 0 | 0 | 0 |
| Net Debt | -13M | -6M | -7M | -10M | -6M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
38M
-29.9% YoY
Capital Expenditures
0
Free Cash Flow
38M
-29.9% YoY
Key ratios
Gross Margin
100.0%
Operating Margin
39.3%
Net Margin
967.9%
ROE
23.5%
Debt / Equity
0.26x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.